Soleno Therapeutics Aktie - SLNO

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

45,18

Gebot

44,84

Fragen

45,35

Volumen

1.251.289

44,19 Tagesbereich 46,57

35,70 52-Wochen-Bereich 60,92

Marktkapitalisierung

1,948B

Handelsende

45,20

Handelsbeginn

44,19

Letzte Trade

45.25

Letzter Handelszeitpunkt

Finanzvolumen

US$ 57.212.343

VWAP

45,7227

Durchschnittliches Volumen (3 Mio.)

677.766

Ausgegebene Aktien

43.117.432

Dividendenrendite

Kurs-Gewinn-Verhältnis

-50,01

Gewinn pro Aktie (EPS)

-0,9

Erlöse

Nettogewinn

-38,99M

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.

Sektor

Electromedical Apparatus

Branche

Electromedical Apparatus

Website

www.capnia.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Soleno Therapeutics Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker SLNO. The last closing price for Soleno Therapeutics was US$45,20. Over the last year, Soleno Therapeutics shares have traded in a share price range of US$ 35,70 to US$ 60,92.

Soleno Therapeutics currently has 43.117.432 shares in issue. The market capitalisation of Soleno Therapeutics is US$1,95 billion. Soleno Therapeutics has a price to earnings ratio (PE ratio) of -50.01.

Gesamtfluss

Bärisch

Nettoprämie

-262k

Calls / Puts

0,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

Form 8-K - Current report

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...

Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...

Form 8-K - Current report

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-1.2	-2.5873221216	46.38	48.77	43.32	680723	46.49627046	CS
4	-9.76	-17.7648343648	54.94	60.92	43.32	757778	50.83518739	CS
12	-3.75	-7.66400980993	48.93	60.92	43.32	677766	52.49855771	CS
26	3.3	7.87965616046	41.88	60.92	36.93	599937	49.51791355	CS
52	7.43	19.6821192053	37.75	60.92	35.7	478597	47.44421762	CS
156	44.633	8159.59780622	0.547	60.92	0.1302	715673	15.25826477	CS
260	43.48	2557.64705882	1.7	60.92	0.1302	801276	8.85724042	CS

SLNO - Frequently Asked Questions (FAQ)

What is the current Soleno Therapeutics share price?

The current share price of Soleno Therapeutics is US$ 45,18

How many Soleno Therapeutics shares are in issue?

Soleno Therapeutics has 43.117.432 shares in issue

What is the market cap of Soleno Therapeutics?

The market capitalisation of Soleno Therapeutics is USD 1,95B

What is the 1 year trading range for Soleno Therapeutics share price?

Soleno Therapeutics has traded in the range of US$ 35,70 to US$ 60,92 during the past year

What is the PE ratio of Soleno Therapeutics?

The price to earnings ratio of Soleno Therapeutics is -50,01

What is the reporting currency for Soleno Therapeutics?

Soleno Therapeutics reports financial results in USD

What is the latest annual profit for Soleno Therapeutics?

The latest annual profit of Soleno Therapeutics is USD -38,99M

What is the registered address of Soleno Therapeutics?

The registered address for Soleno Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Soleno Therapeutics website address?

The website address for Soleno Therapeutics is www.capnia.com

Which industry sector does Soleno Therapeutics operate in?

Soleno Therapeutics operates in the ELECTROMEDICAL APPARATUS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MYSZMy Size Inc	US$ 4,2001 (211,12%)	121,03M
NVNINVNI Group Ltd	US$ 8,26 (209,36%)	78,06M
TPICTPI Composites Inc	US$ 2,45 (100,82%)	34M
ICGIntchains Group Ltd	US$ 8,77 (88,60%)	527,94k
HSDTHelius Medical Technologies Inc	US$ 0,884851 (84,34%)	121,95M
CYNCYNGN Inc	US$ 0,4603 (-71,41%)	27,91M
MTEMMolecular Templates Inc	US$ 0,1502 (-57,09%)	8,75M
PRFXPainReform Ltd	US$ 5,15 (-53,85%)	2,94M
GALTGalectin Therapeutics Inc	US$ 1,03 (-48,50%)	9,27M
BCABBioAtla Inc	US$ 0,6923 (-41,82%)	6,25M
EDBLEdible Garden AG Inc	US$ 0,24 (65,06%)	354,32M
APTOAptose Biosciences Inc	US$ 0,28 (64,51%)	305,1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,606999 (6,49%)	292,16M
NVDANVIDIA Corporation	US$ 134,70 (3,08%)	287,21M
PLTRPalantir Technologies Inc	US$ 80,55 (8,54%)	277,63M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Soleno Therapeutics Inc (SLNO) Börsenkurse

Soleno Therapeutics Inc (SLNO)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Soleno Therapeutics Inc

Option-Flow Soleno Therapeutics (SLNO)

Gesamtfluss

Bärisch

Nettoprämie

-262k

Calls / Puts

0,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

SLNO Neueste Nachrichten

SLNO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen